Advertisement
Research Article| Volume 16, ISSUE 3, P202-209, April 2006

Download started.

Ok

Effects of pistachio nuts consumption on plasma lipid profile and oxidative status in healthy volunteers

Published:February 09, 2006DOI:https://doi.org/10.1016/j.numecd.2005.08.004

      Abstract

      Background and aim

      Effects of pistachio nuts consumption on plasma lipid profile and oxidative status were investigated in healthy volunteers with normal lipid levels.

      Methods and results

      The study was conducted in 24 healthy men and 20 healthy women. All subjects consumed their regular diets during a 1-week period. After this period, half of the subjects (12 men and 10 women, mean age 32.8 ± 6.7 years) were randomized to a regular diet group and the other half (12 men and 10 women, mean age 33.4 ± 7.2 years) were randomized to a pistachio group which involved substituting pistachio nuts for 20% of their daily caloric intake for 3 weeks. Plasma total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride, malondialdehyde (MDA) and antioxidant potential (AOP) were measured before and after the dietary modification from all the subjects. After 3 weeks, with the pistachio diet, the mean plasma total cholesterol, MDA levels and, total cholesterol/HDL and LDL/HDL ratios were found to be significantly decreased (P < 0.05, P < 0.05, P < 0.001 and P < 0.01, respectively); on the contrary, HDL and AOP levels, and AOP/MDA ratios were significantly increased (P < 0.001, P < 0.05 and P < 0.01, respectively). Triglyceride and LDL levels also decreased but this was not statistically significant (P > 0.05).

      Conclusion

      These results indicated that consumption of pistachio nuts decreased oxidative stress, and improved total cholesterol and HDL levels in healthy volunteers.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Nutrition, Metabolism and Cardiovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kris-Etherton P.M.
        • Zahao G.
        • Binkoski A.E.
        • Coval S.M.
        • Etherton T.D.
        The effects of nuts on coronary heart disease risk.
        Nutr Rev. 2001; 59: 103-111
        • Hu F.B.
        • Willett W.C.
        Optimal diets for prevention of coronary heart disease.
        JAMA. 2002; 288: 2569-2578
        • Kris-Etherton P.M.
        • Yu-Poth S.
        • Sabate J.
        • Rateliffe H.E.
        • Zahao G.
        • Etherton T.D.
        Nuts and their bioactive constituents: effects on plasma lipids and other factors that affect disease risk.
        Am J Clin Nutr. 1999; 70: 504-511
        • Hu F.B.
        • Stampfer M.J.
        • Manson J.E.
        • Rimm E.B.
        • Colditz G.A.
        • Rosner B.A.
        • et al.
        Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study.
        BMJ. 1998; 317: 1341-1345
        • Rainey C.
        Nyquist. Nuts—nutrition and health benefits of daily use.
        Nutr Today. 1997; 32: 157-163
        • Rimm E.B.
        • Stampfer M.J.
        The role of antioxidants in preventive cardiology.
        Curr Opin Cardiol. 1997; 12: 188-194
        • Kovacheva S.
        • Ribarov S.R.
        Lipid peroxidation in lung of rats stressed by immobilization: Effects of vitamin E supplementation.
        Lungs. 1995; 173: 255-263
        • Blomhoff R.
        Dietary antioxidants and cardiovascular disease.
        Curr Opin Lipidol. 2005; 16: 47-54
        • Koracevic D.
        • Koracevic G.
        • Djordjevic V.
        • Andrejevic S.
        • Cosic V.
        Method for measurements of antioxidant activity in human fluids.
        J Clin Pathol. 2001; 54: 356-361
        • Woodford F.P.
        • Whitehead T.P.
        Is measuring serum antioxidant capacity clinicall useful?.
        Ann Clin Biochem. 1998; 35: 48-56
        • Rumley A.G.
        • Peterson J.R.
        Analytical aspect of antioxidants and free radical activity in clinical biochemistry.
        Ann Clin Biochem. 1998; 35: 181-200
        • Samir M.
        • el Kholy N.M.
        Thiobarbituric acid reactive substances in patients with laryngeal cancer.
        Clin Otolaryngol. 1999; 24: 232-234
        • Jung H.H.
        • Choi D.H.
        • Lee S.H.
        Serum malondialdehyde and coronary artery disease in hemodialysis patients.
        Am J Nephrol. 2004; 24: 537-542
        • Lasheras C.
        • Gonzalez S.
        • Huerta J.M.
        • Braga S.
        • Patterson A.M.
        • Fernandez S.
        Plasma iron is associated with lipid peroxidation in an elderly population.
        J Trace Elem Med Biol. 2003; 17: 171-176
        • Kamal A.
        • Komaa A.
        • Khafif M.
        • Hammad A.
        Plasma lipid peroxides among workers exposed to silica or asbestos dusts.
        Environ Res. 1989; 49: 173-180
        • Alper C.M.
        • Mattes R.D.
        Peanut consumption improves indices of cardiovascular disease risk in healthy adults.
        J Am Coll Nutr. 2003; 22: 133-141
        • Pinzani P.
        • Petruzzi E.
        • Orlando C.
        • Gallai R.
        • Serio M.
        • Pazzagli M.
        Serum antioxidant capacity in healthy and diabetic subjects as determined by enhanced chemiluminescence.
        J Biolumin Chemilumin. 1998; 13: 321-325
        • Fraser G.E.
        • Sabate J.
        • Besson W.L.
        • Strahan T.M.
        A possible protective effect of nut consumption on risk of coronary heart disease: the Adventist health study.
        Arch Intern Med. 1992; 152: 1416-1424
        • Durak I.
        • Köksal I.
        • Kacmaz M.
        • Buyukkocak S.
        • Cimen B.M.Y.
        • Ozturk H.S.
        Hazelnut supplementation enhances plasma antioxidant potential and lowers plasma cholesterol levels.
        Clin Chim Acta. 1999; 284: 113-115
        • Sabate J.
        • Fraser G.E.
        • Burke K.
        • Knutsen S.F.
        • Bennett H.
        • Lindsled K.
        Effect of walnut on serum lipid levels and blood pressure in normal men.
        N Eng J Med. 1993; 328: 603-607
        • Abbey M.
        • Noakes M.
        • Belling G.B.
        • Nestel P.J.
        Partial replacement of saturated fatty acids with almonds or walnuts lowers total plasma cholesterol and low-density-lipoprotein cholesterol.
        Am J Clin Nutr. 1994; 59: 995-999
        • Spiller G.A.
        • Jenkins D.J.A.
        • Cragen L.N.
        • Gates J.E.
        • Bosello O.
        • Berra K.
        • et al.
        Effect of a diet high in monounsaturated fat from almonds on plasma cholesterol and lipoproteins.
        Am J Clin Nutr. 1992; 11: 126-130
        • Edwards K.
        • Kwaw I.
        • Matud J.
        • Kurtz I.
        Effect of pistachio nuts on serum lipid levels in patients with moderate hypercholesterolemia.
        J Am Coll Nutr. 1999; 18: 229-232
        • Kris-Etherton P.M.
        Monounsaturated fatty acids and risk of cardiovascular disease.
        Circulation. 1999; 100: 1253-1258
        • Maizer M.J.
        • Jones P.J.
        Diet fat saturation and feeding state modulate rates of cholesterol synthesis in normolipidemic men.
        J Nutr. 1996; 127: 332-340
        • Andersen J.W.
        • Smith B.M.
        • Gustafson N.
        Health benefit and practical aspects of high fiber diets.
        Am J Clin Nutr. 1994; 59: 1242-1247
        • Jones P.J.
        • MacDougall D.E.
        • Ntanios F.
        • Vanstone C.A.
        Dietary phytosterols as cholesterol-lowering agents in humans.
        Can J Physiol Pharmacol. 1997; 75: 217-227
        • Jenkins D.J.
        • Wolever T.M.
        • Rao A.V.
        • Hegele R.A.
        • Mitchell S.J.
        • Ransom T.P.
        • et al.
        Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol.
        N Engl J Med. 1993; 329: 21-26
        • Anderson J.W.
        • Hanna T.J.
        • Peng X.
        • Kryscio R.J.
        Whole grain foods and heart disease risk.
        J Am Coll Nutr. 2000; 19: 291-299
        • Anderson J.W.
        • Tietyen-Clark J.
        Dietary fiber: hyperlipidemia, hypertension and coronary artery disease.
        Am J Gastroenterol. 1986; 81: 907-919
        • Nishima P.M.
        • Freedland R.A.
        The effects of dietary fiber feeding on cholesterol metabolism in rats.
        J Nutr. 1990; 120: 800-805
        • Vajifdar B.U.
        • Goyal V.S.
        • Lokhandwala Y.Y.
        • Mhamunkar S.R.
        • Mahadik S.P.
        • Gawad A.K.
        • et al.
        Is dietary fiber beneficial in chronic ischemic heart disease?.
        J Assoc Physicians India. 2000; 48: 871-876
        • Durak I.
        • Köksal I.
        • Kacmaz M.
        • Buyukkocak S.
        • Cimen B.M.Y.
        • Ozturk H.S.
        Hazelnut supplementation enhance plasma antioxidant potential and lowers plasma cholesterol levels.
        Clin Chim Acta. 1999; 284: 113-115
        • McCord J.M.
        Human disease, free radicals, and the oxidant/antioxidant balance.
        Clin Biochem. 1993; 26: 351-357
        • Morenoa J.J.
        • Mitjavilab M.T.
        The degree of unsaturation of dietary fatty acids and the development of atherosclerosis.
        J Nutr Biochem. 2003; 14: 182-195
        • Fraser G.E.
        • Bennett H.W.
        • Jaceldo K.B.
        • Sabate J.
        Effect on body weight of a free 76 kilojoule (320 calorie) supplement of almonds for six months.
        J Am Coll Nutr. 2002; 21: 275-283
        • Fraser G.E.
        Nut consumption, lipids, and risk of a coronary event.
        Clin Cardiol. 1999; 22: 11-15